Triptolide can induce the apoptosis of cisplatin-resistant ovarian cancer cells and sensitize them to cisplatin fifty two. A variety of transcription aspects, proteins and signaling pathways are involved in the antitumor outcomes of triptolide, but its anticancer impact is especially attained by